Article info

Download PDFPDF
Original research
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma

Authors

  1. Correspondence to Professor Alfred Sze-Lok Cheng, The Chinese University of Hong Kong, Hong Kong, China; alfredcheng{at}cuhk.edu.hk
View Full Text

Citation

Liu M, Zhou J, Liu X, et al
Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma

Publication history

  • Received July 27, 2018
  • Revised March 1, 2019
  • Accepted April 15, 2019
  • First published May 10, 2019.
Online issue publication 
January 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.